Defining roles of innate lymphoid cells in chronic kidney disease for future therapy

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic kidney disease is a major cause of death and morbidity in Australia. Current strategies that delay progression of kidney disease are limited. Innate lymphoid cells are a newly identified heterogeneous family of immune cells, which have important roles in tissue homeostasis and pathologic inflammation. The central aims of the project are to define the role of innate lymphoid cells in chronic kidney disease, and further to explore their therapeutic potential in kidney disease.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $638,825.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nephrology and Urology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic renal failure | immunotherapy | inflammation | innate immunity | nephropathy